Epidemiology of multimorbidity in Nepal: A systematic review and meta-analysis.

Journal of multimorbidity and comorbidity Pub Date : 2024-09-14 eCollection Date: 2024-01-01 DOI:10.1177/26335565241284022
Abhinav Sinha, S Shradha Suman, Narayan Subedi, Krushna Chandra Sahoo, Mukesh Poudel, Arohi Chauhan, Banamber Sahoo, Marjan van den Akker, David Weller, Stewart W Mercer, Sanghamitra Pati
{"title":"Epidemiology of multimorbidity in Nepal: A systematic review and meta-analysis.","authors":"Abhinav Sinha, S Shradha Suman, Narayan Subedi, Krushna Chandra Sahoo, Mukesh Poudel, Arohi Chauhan, Banamber Sahoo, Marjan van den Akker, David Weller, Stewart W Mercer, Sanghamitra Pati","doi":"10.1177/26335565241284022","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multimorbidity is rising in low-and middle-income countries such as Nepal, yet the research has not gained pace in this field. We aimed to systematically review the existing multimorbidity literature in Nepal and estimate the prevalence and map its risk factors and consequences.</p><p><strong>Methods: </strong>We reviewed data collated from PubMed, Embase and CINAHL by including original studies that reported prevalence of multimorbidity in Nepal. The quality of included studies was assessed using the Appraisal Tool for Cross-sectional Studies. The summary of the review is presented both qualitatively as well as through meta-analysis to give pooled prevalence. We prospectively registered in PROSPERO (CRD42024499598).</p><p><strong>Results: </strong>We identified 423 studies out of which seven were included in this review. All studies were conducted in a community setting except one which was hospital based. The prevalence reported across various studies ranged from 13.96% to 70.1%. The pooled prevalence of multimorbidity was observed to be 25.05% (95% CI: 16.99 to 34.09). The number of conditions used to assess multimorbidity ranged from four to nine. The major risk factors identified were increasing age, urban residence, and lower literacy rates.</p><p><strong>Conclusion: </strong>A wide variance in the prevalence of multimorbidity was observed. Moreover, multimorbidity assessment tool/conditions considered for assessing multimorbidity were heterogeneous.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241284022"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11409287/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of multimorbidity and comorbidity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26335565241284022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Multimorbidity is rising in low-and middle-income countries such as Nepal, yet the research has not gained pace in this field. We aimed to systematically review the existing multimorbidity literature in Nepal and estimate the prevalence and map its risk factors and consequences.

Methods: We reviewed data collated from PubMed, Embase and CINAHL by including original studies that reported prevalence of multimorbidity in Nepal. The quality of included studies was assessed using the Appraisal Tool for Cross-sectional Studies. The summary of the review is presented both qualitatively as well as through meta-analysis to give pooled prevalence. We prospectively registered in PROSPERO (CRD42024499598).

Results: We identified 423 studies out of which seven were included in this review. All studies were conducted in a community setting except one which was hospital based. The prevalence reported across various studies ranged from 13.96% to 70.1%. The pooled prevalence of multimorbidity was observed to be 25.05% (95% CI: 16.99 to 34.09). The number of conditions used to assess multimorbidity ranged from four to nine. The major risk factors identified were increasing age, urban residence, and lower literacy rates.

Conclusion: A wide variance in the prevalence of multimorbidity was observed. Moreover, multimorbidity assessment tool/conditions considered for assessing multimorbidity were heterogeneous.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
尼泊尔多病流行病学:系统回顾和荟萃分析。
背景:尼泊尔等中低收入国家的多病症发病率正在上升,但这一领域的研究却没有取得进展。我们的目的是系统回顾尼泊尔现有的多病症文献,估算多病症的发病率,并绘制其风险因素和后果图:我们查阅了从 PubMed、Embase 和 CINAHL 收集的数据,包括报告尼泊尔多病流行情况的原创研究。采用横断面研究评估工具对纳入研究的质量进行了评估。综述既有定性分析,也有通过荟萃分析得出的汇总患病率。我们在 PROSPERO(CRD42024499598)上进行了前瞻性注册:结果:我们确定了 423 项研究,其中 7 项被纳入本综述。所有研究都是在社区环境中进行的,只有一项研究是在医院进行的。各项研究报告的患病率从 13.96% 到 70.1% 不等。据观察,多病共存的患病率为 25.05%(95% CI:16.99 至 34.09)。用于评估多病症的病症数量从 4 种到 9 种不等。发现的主要风险因素是年龄增长、居住在城市和识字率较低:结论:多病症患病率差异很大。此外,多病评估工具/多病评估条件也不尽相同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Associations of HIV and prevalent type 2 diabetes mellitus in the context of obesity in South Africa. Comparison of the quality of life of comorbid and non-comorbid people living with HIV/AIDS in a Nigerian secondary healthcare facility. Corrigendum to "Eliciting and prioritising determinants of improved care in multimorbidity: A modified online Delphi study". Developing SysteMatic: Prevention, precision and equity by design for people living with multiple long-term conditions. Corrigendum to "Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1